Vortex Energy Stock Quote VRTX - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.05

Bid

0.045

Ask

0.06

Volume

304,078

0.05 Day's Range 0.06

0.04 52 Week Range 0.52

Previous Close

0.055

Open

0.06

Last Trade

214

0.05

Last Trade Time

Average Volume (3m)

134,324

Financial Volume

VWAP

Vertex Pharmaceuticals Announces the Date of its Third Quarter 2006 Financial Results Conference Call and Webcast

CAMBRIDGE, Mass., Oct. 9 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated (Nasdaq GS: VRTX) will announce its third quarter 2006 financial results on Thursday, October 26, 2006...

Vertex Pharmaceuticals Announces Completion of Common Stock Offering

CAMBRIDGE, Mass., Sept. 20 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated (Nasdaq GS: VRTX) today announced the completion of its public offering of 9,100,000 shares of common...

Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor Conferences

CAMBRIDGE, Mass., Sept. 18 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated (Nasdaq GS: VRTX) will webcast corporate presentations at Merrill Lynch's Global Pharmaceutical, Biotech...

Vertex Pharmaceuticals Announces Pricing of Common Stock Offering

CAMBRIDGE, Mass., Sept. 14 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated (Nasdaq GS: VRTX) today announced the pricing of its public offering of 9,100,000 shares of its common...

Vertex and Merck Initiate Clinical Study in Hematologic Cancers with Aurora Kinase Inhibitor VX-680

Vertex and Merck Initiate Clinical Study in Hematologic Cancers with Aurora Kinase Inhibitor VX-680 WHITEHOUSE STATION, N.J. and CAMBRIDGE, Mass., June 17 /PRNewswire/ -- Merck & Co., Inc...

Vertex Pharmaceuticals Reports Positive Results from First-in-Human Study for VX-950, an Investigational Oral Protease Inhibitor

Vertex Pharmaceuticals Reports Positive Results from First-in-Human Study for VX-950, an Investigational Oral Protease Inhibitor for the Treatment of Hepatitis C -- Encouraging Results Support...

Studies of Sustained Efficacy/Tolerability of LEXIVA After 96 Weeks of Treatment Presented at IAC

Studies of Sustained Efficacy/Tolerability of LEXIVA After 96 Weeks of Treatment Presented at IAC BANGKOK, Thailand, July 13 /PRNewswire-FirstCall/ -- The protease inhibitor (PI) LEXIVA(R...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.005	11.1111111111	0.045	0.06	0.045	67450	0.0507739	CS
4	0	0	0.05	0.06	0.04	95061	0.04392037	CS
12	-0.01	-16.6666666667	0.06	0.065	0.04	134324	0.04758356	CS
26	-0.13	-72.2222222222	0.18	0.2	0.04	117331	0.07524493	CS
52	-0.46	-90.1960784314	0.51	0.52	0.04	120552	0.19207967	CS
156	-0.05	-50	0.1	2.32	0.04	194235	0.86778208	CS
260	-0.05	-50	0.1	2.32	0.04	194235	0.86778208	CS

VRTX - Frequently Asked Questions (FAQ)

What is the current Vortex Energy share price?

The current share price of Vortex Energy is $ 0.05

What is the 1 year trading range for Vortex Energy share price?

Vortex Energy has traded in the range of $ 0.04 to $ 0.52 during the past year

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
LTHMChampion Electric Metals Inc	$ 0.015 (200.00%)	1,000
PUMPStock Trend Capital Inc	$ 0.01 (100.00%)	2.03M
CATCAT Strategic Metals Corporation	$ 0.01 (100.00%)	5.4k
AFXArctic Fox Lithium Corp	$ 0.01 (100.00%)	10k
FFF55 North Mining Inc	$ 0.01 (100.00%)	150.18k
CCRGreen River Gold Corp	$ 0.005 (-50.00%)	8k
CRVCCross River Ventures Corp	$ 0.005 (-50.00%)	200k
VTALJustera Health Ltd	$ 0.005 (-50.00%)	3.8M
HECOGlobal Helium Corp	$ 0.03 (-40.00%)	225k
RAMMRamm Pharma Corp	$ 0.015 (-40.00%)	2.5k
HVWHi View Resources Inc	$ 0.06 (9.09%)	3.92M
VTALJustera Health Ltd	$ 0.005 (-50.00%)	3.8M
GSRIGolden Shield Resources Inc	$ 0.03 (-14.29%)	2.18M
PUMPStock Trend Capital Inc	$ 0.01 (100.00%)	2.03M
PRMEPrime Drink Group Corp	$ 0.22 (4.76%)	1.98M